AstraZeneca Pharma - we had a pilot position @1940 and we added more today@2136
3 yr average sales growth - 4%
3 yr average profit growth - 120%
3 yr average margin growth - 200%
The sales growth is not very impressive however the company was making losses from 2013-2015 and it has turned around since 2016. We will be watching the upcoming quarters for a further cue in the improvement of sales and we will also look for guidance from the annual reports.
3 yr average sales growth - 4%
3 yr average profit growth - 120%
3 yr average margin growth - 200%
The sales growth is not very impressive however the company was making losses from 2013-2015 and it has turned around since 2016. We will be watching the upcoming quarters for a further cue in the improvement of sales and we will also look for guidance from the annual reports.
Value doesn't move stock prices, people do by placing buy orders. Value is only part of the equation. Ultimately, you need demand - Mark Minervini
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
Value doesn't move stock prices, people do by placing buy orders. Value is only part of the equation. Ultimately, you need demand - Mark Minervini
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。